SAMA and SABA + SAMA use associated with increased risk for heart failure, arrhythmia, and mortality versus no use ...
Chronic lower respiratory diseases, namely, asthma and chronic obstructive pulmonary disease (COPD), are the fifth-leading cause of death in the United States. A contributing factor is diagnostic ...
Communities impacted by increased wildfire activity and smoke can use a population health-based action plan to help alleviate health risks, particularly for those with chronic obstructive pulmonary ...
Mississippi awarded more than $104 million in federal rural health grants across 167 projects. Where the money goes and why rural access matters. Rural Virginia Paramedics Make Home Visits to Cut ...
Based on real-world records from the U.K., affected patients who went on any GLP-1 receptor agonist for a comorbid condition ...
Patients with asthma or COPD who used semaglutide for type 2 diabetes experienced significant reductions in their ...
The diabetes and weight-loss injection semaglutide can reduce asthma attacks by up to 40%, according to research presented at ...
A diagnostic algorithm was evaluated for its ability to gauge the presence of asthma or chronic obstructive pulmonary disease (COPD), in a new analysis. An asthma/chronic obstructive pulmonary disease ...
Morning Overview on MSN
The drug in Ozempic is linked to about 40 per cent fewer asthma attacks
the semaglutide respiratory finding is the specific development at the center of this account. At Semaglutide, the available ...
Connect Biopharma’s hopes of dethroning Dupixent took a knock as its IL-4/IL-13 blocker missed the primary endpoint of a ...
Semaglutide, the drug found in Ozempic and Wegovy, was linked to nearly 40% fewer asthma attacks in a large real-world study. It was also associated with about 20% fewer COPD flare-ups. Researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results